Revenues for the quarter ended March 31 fell to $865,000 from $1.52 million during the same period last year. Around $384,000 of those receipts came from government and other grants.
R&D expenses increased to $3.5 million from $2.9 million during the same quarter in 2004.
The company's net loss for the quarter increased to $3.74 million, or $.13 per share, from $3 million, or $.11 per share, for the same quarter last year.
As of March 31, Compugen had $43.5 million in cash, cash equivalents, and marketable securities, of which $23.78 million are long-term marketable securities.